Morgan Stanley Raises Price Target on Best Buy (BBY) to $35 Following Solid 2Q
- Wall St. set to rise ahead of Trump inauguration
- General Electric (GE) Reports In-Line Q4 EPS
- Procter & Gamble (PG) Tops Q2 EPS by 2c
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Dollar recoups losses, caution sets in ahead of Trump inauguration
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Morgan Stanley reiterated an Equalweight rating on Best Buy (NYSE: BBY), and raised the price target to $35.00 (from $28.00), following the company's 2Q earnings report. Q2 comps were better than expected at +0.8% vs. consensus estimates of -0.4%, and Q3 comp guidance of +1% is solid and suggests QTD trends are running higher.
Analyst Simeon Gutman commented, "BBY is asserting its relevance in the CE category with strong execution and is being rewarded with market share gains. These gains helped drive a Q2 beat and a good start to the all-important 2H. Raising price target to $35."
Shares of Best Buy closed at $39.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Drexel Hamilton Reiterates Buy on IBM (IBM) Following 4Q Report
- Skyworks Solutions (SWKS) PT Raised to $96 at Canaccord Genuity
- Web.com, Inc. (WEB) PT Raised to $25 at BWS Financial Ahead of 4Q Report
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesMorgan Stanley, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!